General Response Rates

(1)

General Response Rates

• 42 Responses

• 28 Programs stated that they had a

PharmD/PhD program and typically

responded to questions about PharmD/PhD

Training

• 16 Programs stated that they had a Clinical

Pharmaceutical Scientist (or similarly named)

Program and responded to questions about

CPS programs.

(2)

Do you currently offer or plan to offer a graduate

program in the Clinical Pharmaceutical Sciences?

45.2%

54.8%

Yes No

(3)

Which of the following describes your School’s/University’s

programmatic offerings for a PhD training in the Clinical

Pharmaceutical Sciences?

56.5%

(13)

13.0%

(3)

30.4%

(7)

Formalized Program

Informal Program

Planning a Program

(4)

Which of the following describes the status

of a combined or joint PharmD/PhD

Program at your institution?

55.0%

(22)

15.0%

30.0%

(12)

Currently Offer a

PharmD/PhD

Planning on Offering a

PharmD/PhD

No Current Plans

(5)

What is the primary background of

admitted students entering your program?

58.6%

(17)

13.8%

(4)

27.6%

(17)

Internal domestic applicants

External domestic applicants

International applicants

(6)

Which best describes the educational

prerequisites for students entering your clinical

pharmaceutical scientist graduate program?

37.5%

(6)

18.8%

43.8%

(7)

Requires a PharmD

Requires a health sciences

doctorate/masters

Accepts students with related

BS or graduate degrees

(7)

Which best describes the admission

requirements for your program?

0.0%

33.3%

(6)

27.8%

(5)

38.9%

(7)

Active professional license in our

state

Health professional background

independent of licensure status

Domestic or international students

with a health professional degree

Any qualified domestic or

international students

(8)

Which of the following best describes

the primary advisor structure?

25.0%

(4)

56.3%

18.8%

(3)

Single individual as their primary

mentor

Either a single individual or co‐

advisors as their primary

mentor(s)

At least two individuals as their

primary mentors (i.e. co‐advisors)

(9)

Describe your Qual or Comp Exam (17 responses)

• Preliminary exam‐‐Students must complete a detailed written research proposal and make an oral presentation of the proposal.

• Written exam, NIH mini‐grant proposal, oral defense

• The examination for PhD candidacy has both a written and oral component. The written component is a research proposal, written in standard NIH format, of their dissertation project. This is provided to the committee 2‐4 weeks in advance of the oral qualifying exam and the committee members must approve of the written proposal before the student can move to the oral qualifying examination. The oral examination focuses on the student's comprehensive knowledge base in the graduate program, and while typically focused to some degree around their dissertation proposal can and does include questions from all their required graduate courses and other courses taken.

• Our qualifying exam consists of the student preparing a 10 page NIH style written grant proposal followed by an oral defense of that proposal in front of their graduate committee. Student in the clinical scientist training program must have a aim of that proposal consisting of a human study.

• For the Doctor of Philosophy program one preliminary written examination is required. With successful completion of the written examination an oral examination is then required. These examinations may be taken by the student when a majority of the plan of study has been completed. Further, these examinations must precede presentation of the dissertation defense at least by two semesters.

• students must have acceptable GRE scores

• We do not have a clinical pharmaceutical science graduate program. However, the general exam in our traditional graduate program is typically open book in which the students are required to address a number of topics over a few days.

• We require the candidate to pass both a written exam and oral presentation.

• Students prepare a grant proposal for the written examination. The oral examination covers the proposal and other areas at the discretion of the committee.

• WE don't currently have this program which is why I have skipped most of these questions

• Evaluation of completed didactic coursework

• _N/A

• The development of the individual as an independent research scientist is a critical component of the Ph.D. degree. The potential for such development is assessed on the basis of both mastery of subject matter and research competency as judged in the context of written and oral examinations administered at the level of the department. Students are admitted to candidacy on the basis of completing required coursework and examinations as required and the recommendation of the Faculty Advisor, Student Advisory Committee and Graduate Program Director. Advancement to candidacy should preferably take place prior to initiating the third academic year in the program.

Written Comprehensive Exam – In Medicinal Chemistry, cumulative examinations will be given whereas in the Departments of Pharmaceutics and Pharmacy a written comprehensive examination will be given. The written examination(s) generally focus(es) on the subject matter deemed critical as a foundation in the particular program. The written examination is largely based on material covered in required course work and its application to theoretical and practical problems. Individual department guidelines should be consulted for greater detail. The written examination is administered by the student's department. In the event of failure of the written comprehensive examination, the student, with the approval of the Director of the Pharmaceutical Sciences Graduate Program, may be permitted to repeat the written examination. The Director of the Pharmaceutical Sciences Graduate Program should be notified in writing of the outcome of the written exam by the student’s Program Director.

• Students prepare a research proposal, take a written examination, and complete an oral examination. Exam questions may, but do not have to, have direct relevance to the student's research project.

• Oral and Written qualifying exam‐‐knowledge of clinical subject and of research methods by written proposal for dissertation.

• Students prepare a written proposal for a research study. Oral questioning is based upon the written proposal.

• The qualifying exam is given after two years of didactic course work in core areas. Exam questions are designed to integrate core subject areas (PK/PD, Drug Metabolism, Pharmacogenomics, Experimental Design/Data Analysis, Pharmaceutical Analysis, Evidence‐Based Medicine). The content emphasized in the qualifying exam is centered on material covered in course work. However, the exam is not be fact‐based but instead integrates the skills and knowledge acquired from course work, research rotations and clinical experiences to all students to demonstrate creative thinking and problem solving ability in addition to breadth and depth of core knowledge. Competency in translational research is demonstrated by the ability to propose hypotheses, identify specific aims, and design experiments from the evaluation of scientific literature and the interpretation of in vivo and in vitro data. Students must pass the qualifying exam before proceeding with the preliminary oral exam and dissertation prospectus,

(10)

Which of the following best describes

the qual or comp exam requirements?

13.3%

(2)

53.3%

33.3%

(5)

Demonstrate their ability to design

a research study in humans

Demonstrate their ability to design

research in humans, but this is not

a requirement

No requirements to demonstrate

ability to design research in

humans

(11)

Which of the following best describes the

composition of graduate dissertation committees

in your Clinical Pharmaceutical Scientist Program?

46.2%

(6)

46.2%

(6)

7.7%

(1)

Required to have individual with

clinical practice expertise

Students are not required, but

frequently have individuals with

clinical practice experience

Students rarely have, and are not

required to have, individuals with

clinical practice expertise

(12)

Which of the following best describes the

dissertation research requirements regarding

human research in your CPS Program?

0.0% ^15.4%

(2)

46.2%

38.5%

(5)

Required to have the majority of

their thesis as prospective human

clinical study

Required to have a significant

portion (e.g., a thesis chapter) as a

prospective human clinical study

Required to have a clinical

component to their research which

includes human cells or clinical

retrospective data

No requirement with respect to

human based studies

(13)

Which of the following best describes the research

rotation requirements your CPS Program?

7.1%

(1)

28.6%

(4)

57.1%

(8)

7.1%

(1) One rotation prior to selecting

an advisor.

Two or more rotations prior to

selecting an advisor.

No rotation requirments

before selecting an advisor.

Students select advisors prior

to entry into the program.

(14)

Which of the following best describes the curricular

offerings for students in your CPS Program as

compared to traditional PhD offerings?

33.3%

(5)

20.0%

26.7%

(4)

20.0%

(3)

Very different set of core courses

Some separate core courses

The same core courses but separate

elective offerings

The same core and elective offerings

(15)

Clinical Pharmaceutical Sciences

14. Please state if each of the following are required (R); elective (E); or Neither (N) <u>didactic elements</u> of your Clinical Pharmaceutical Scientist Graduate Program:

Answer Options Required Elective Neither Response Count

Biostatistics ¹⁵ ⁰ ¹ ¹⁶

Advanced Statistical Methods ⁷ ⁷ ¹ ¹⁵

Ethics of Clinical Research ¹¹ ² ² ¹⁵

Pharmacokinetics ¹¹ ³ ¹ ¹⁵

Modeling and Simulation ² ⁹ ⁴ ¹⁵

Pharmacogenetics ⁸ ⁵ ² ¹⁵

Grant Writing ⁸ ⁶ ¹ ¹⁵

Teaching Methods ⁴ ⁵ ⁶ ¹⁵

Pharmacoepidemiology ⁰ ⁸ ⁷ ¹⁵

Clinical Trial Design ¹⁰ ³ ² ¹⁵

Method for Assessment of Health Outcomes ¹ ⁸ ⁶ ¹⁵

Biomarker Validation ² ⁶ ⁷ ¹⁵

Drug Metabolism / Transport ⁹ ⁵ ² ¹⁶

Advanced Pharmacotherapy ⁶ ⁵ ⁴ ¹⁵

Question Totals

answered question 16

skipped question 29

(16)

Which of the following describes the clinical experiential

opportunities during the PhD training portion of your

Clinical Pharmaceutical Scientist Program?

42.9%

(6)

14.3%

(2)

28.6%

(4)

All students are required to have

clinical rotations

The majority of students have clinical

rotations/clinical practices

experiences but they are not required

Some students have clinical

rotations/clinical practice experiences

but they are not required

Few to no students have clinical

(17)

Which of the following best describes the IRB

submission requirements for CPS Students?

28.6%

(4)

50.0%

(7)

21.4%

(3)

Required to prepare an IRB

submission

The majority of the students

prepare an IRB submission but not

required

Few students prepare an IRB

submission

(18)

Which of the following best describes the

publication requirements for CPS Students?

23.1%

(3)

0.0%

76.9%

(10)

Required to have published at least

one manuscript

Required to have published at least

two manuscripts

There are no publication

requirements

(19)

Clinical Pharmaceutical Sciences

18. Your Clinical Pharmaceutical Scientist Graduate Program currently <u>pays</u> for:

Answer Options Response Average Response Total Response Count

Stipend support (amount) ^24,916.67 ^299,000 ¹²

In-state tuition (amount or percent) ^2,364.64* ^26,011 ¹¹

Out-of-state tuition (amount or percent) ^4,011.10* ^40,111 ¹⁰

Fees (amount or percent) ^379.00* ^3,790 ¹⁰

* Mixed response because some are as percent and others are as total amount

(20)

Which of the following describes your programs

position with respect to external health professional

employment?

58.3%

(7)

33.3%

(4)

8.3%

(1)

Allowed

Encouraged

Discouraged

Not allowed

(21)

Which of the following describes the primary

mechanism for student stipend support in the early

years within your graduate program?

50.0%

(8)

25.0%

(4)

6.3%

(1)

18.8%

(3)

Supported by teaching

assistantship

Supported by research

assistantship

Supported by provision of

clinical services

Other

(22)

Clinical Pharmaceutical Sciences

21. How many years of support are provided by the institution (i.e. not by primary mentor grant support)?

Answer Options Response Count

16

Number Response Date Response Text

1 Aug 24, 2009 8:38 PM 2

2 Aug 24, 2009 9:08 PM 1

3 Aug 25, 2009 2:37 PM 2

4 Aug 25, 2009 4:20 PM 2

5 Aug 25, 2009 5:37 PM varies; 2 or less considered optimal

6 Aug 26, 2009 1:25 AM 4-5 years

7 Aug 26, 2009 12:53 PM 5

8 Aug 26, 2009 7:43 PM 0

9 Sep 1, 2009 5:38 PM 4

10 Sep 1, 2009 7:42 PM Usually 2

11 Sep 5, 2009 6:46 PM 2

12 Sep 8, 2009 5:22 PM variable

13 Sep 15, 2009 12:09 AM Usually 3, some studnets come with complete funding (eg. government)

14 Sep 16, 2009 10:15 PM 0

(23)

Which of the following best describes the role of

faculty from other schools of the health sciences in

your Clinical graduate program?

38.5%

(5)

38.5%

(5)

23.1%

(3)

Fully Integrated

Partially Integrated

Committee Involvement Only

(24)

Do faculty members in your school serve as directors for CTSA supported core facilities?

If yes, please describe what facilities (17 Responses)

yes ‐ basic science/equipment core

NMR/Mass spec facility

yes

Yes, Genotyping Core Laboratory, Comprehensive Drug Development Program

Yes. Faculty members from the School of Pharmacy serve as the directors of the

proteomics core and the small molecule biomarker core facilities.

No

Clinical Research Centers; Core Lab Facilities

Yes. Chair of GCRC Advisory Committee

No

yes, translational technologies director

No

Yes. Experimental Pharmacology.

No

Analytical Core Facility Director

yes, Clinical Trials Unit in Hospital

Pharmacometrics

(25)

Do faculty members in your school serve as members of executive committees, curriculum

committees, or integrated research committees associated with the CTSA? If yes, please

describe the role of faculty in this capacity. (16 responses)

• yes ‐ Dean member of internal advisory committee; faculty on a number of committees

including educational K30, informatics, clinical trials unit and regulatory

• Board of Governors, Faculty Governance Committee, Scientific Review Panel (pre‐IRB), IRB,

KL2 Scholar Selection, graduate student advisory committees

• yes

• Yes, members from our school on all major CTSA committees

• Yes. Faculty members and the Dean serve on the exective committee. Faculty members from

the School serve on the curriculum committee and chair the Core Curriculum

committee. Several faculty members from the School have been appointments to the

CTSI.

• No

• Fully integratged in all committees listed

• Two currently: Member of excecutive committee; member of MS in CTS advisory committee

• Yes, we have faculty serving on the curriculum committee and integrated research commitees

• Yes, members on steering committee and research education committee

• Yes, several members are on a pending CTSA application

• Membership on the Scientific Review Panel for the CTRC

• Yes, on IT committee and education committee

• no

• Yes, executive cmtes, research cmtes

• Executive and curriculum committees

(26)